Subtype and pathway specific responses to anticancer compounds in breast cancerLaura M. Heiser, Paul T. Spellman, Jessica I. Billig et al.|Proceedings of the National Academy of Sciences|2011Cited by 505
Activity of the Kinesin Spindle Protein Inhibitor Ispinesib (SB-715992) in Models of Breast CancerJames W. Purcell, Sylvaine Cases, Mamatha Reddy et al.|Clinical Cancer Research|2010Cited by 95
Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E. Korkola, Joe W. Gray, Eric A. Collisson et al.|PLoS ONE|2015Cited by 28
Abstract 1979: Algebraic factorization of gene expression profiles reveals subtype-specific drug sensitivities among 54 breast cancer cell linesWilliam J. Gibb, Joe W. Gray, Eric A. Collisson et al.|Cancer Research|2010Cited by 0
Correction: Decoupling of the PI3K Pathway via Mutation Necessitates Combinatorial Treatment in HER2+ Breast CancerJames E. Korkola, Joe W. Gray, Eric A. Collisson et al.|PLoS ONE|2017Cited by 0